Yoshihiro Kaku

Yoshihiro Kaku

Auto-generated profile, based on publicly available information

Yoshihiro Kaku

Department of Veterinary Science, National Institute of Infectious Diseases, 1-23-1 Toyama, Tokyo 162-8640, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Virus Research
Verified
Journal Article
Open access
MNMakoto Nagai
Makoto Nagai
TOTsutomu Omatsu
Tsutomu Omatsu
HAHiroshi Aoki
Hiroshi Aoki
YKYoshihiro Kaku
Yoshihiro Kaku
GBGraham Belsham
Graham Belsham
TMTetsuya Mizutani
Tetsuya Mizutani
We identified novel viruses in feces from cattle with diarrhea collected in 2009 in Hokkaido Prefecture, Japan, by using a metagenomics approach and determined the (near) complete sequences of the virus. Sequence analyses revealed that they had a standard picornavirus genome organization, i.e. 5' untranslated region (UTR) - L- P1 (VP4- VP3- VP2- VP1) - P2 (2A- 2B- 2C) - P3 (3A- 3B- 3C-3D) - 3'UTR- poly(A). They are closely related to other unclassified Chinese picornaviruses; bat picornaviruses group 1-3, feline picornavirus, and canine picornavirus, sharing 45.4-51.4% (P1), 38.0-44.9% (P2), and 49.6-53.3% (P3) amino acid identities, respectively. The phylogenetic analyses and detailed genome characterization showed that they, together with the unclassified Chinese picornaviruses, grouped as a cluster for the P1, 2C, 3CD and VP1 coding regions. These viruses had conserved features (e.g. predicted protein cleavage sites, presence of a leader protein, 2A, 2C, 3C, and 3D functional domains), suggesting they have a common ancestor. Reverse-transcription-PCR assays, using specific primers designed from the 5'UTR sequence of these viruses, showed that 23.0% (20/87) of fecal samples from cattle with diarrhea were positive, indicating the prevalence of these picornavirus in the Japanese cattle population in Hokkaido Prefecture. However, further studies are needed to investigate the pathogenic potential and etiological role of these viruses in cattle.

28 April 2024 in Viruses
Verified
Journal Article
Open access
PDF file
MHMichiko Harada
Michiko Harada
AMAya Matsuu
Aya Matsuu
YKYoshihiro Kaku
Yoshihiro Kaku
AOAkiko Okutani
Akiko Okutani
YIYusuke Inoue
Yusuke Inoue
KMKen Maeda
Ken Maeda
Rabies is a fatal encephalitic infectious disease caused by the rabies virus (RABV). RABV is highly neurotropic and replicates in neuronal cell lines in vitro. The RABV fixed strain, HEP-Flury, was produced via passaging in primary chicken embryonic fibroblast cells. HEP-Flury showed rapid adaptation when propagated in mouse neuroblastoma (MNA) cells. In this study, we compared the growth of our previously constructed recombinant HEP (rHEP) strain—based on the sequence of the HEP (HEP-Flury) strain—with that of the original HEP strain. The original HEP strain exhibited higher titer than rHEP and a single substitution at position 80 in the matrix (M) protein M(D80N) after incubation in MNA cells, which was absent in rHEP. In vivo, intracerebral inoculation of the rHEP-M(D80N) strain with this substitution resulted in enhanced viral growth in the mouse brain and a significant loss of body weight in the adult mice. The number of viral antigen-positive cells in the brains of adult mice inoculated with the rHEP-M(D80N) strain was significantly higher than that with the rHEP strain at 5 days post-inoculation. Our findings demonstrate that a single amino acid substitution in the M protein M(D80N) is associated with neurovirulence in mice owing to adaptation to mouse neuronal cells.

1 July 2019 in Journal of Virological Methods
Verified
Journal Article
Closed access
YKYoshihiro Kaku
Yoshihiro Kaku
EPEun-Sil Park
Eun-Sil Park
ANAkira Noguchi
Akira Noguchi
SISatoshi Inoue
Satoshi Inoue
RLRoss Lunt
Ross Lunt
SMShigeru Morikawa
Shigeru Morikawa

1 January 2024 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
YIYusuke Inoue
Yusuke Inoue
YKYoshihiro Kaku
Yoshihiro Kaku
MHMichiko Harada
Michiko Harada
KIKeita Ishijima
Keita Ishijima
YKYudai Kuroda
Yudai Kuroda
KMKen Maeda
Ken Maeda
Rabies is a fatal zoonotic, neurological disease caused by rabies lyssavirus (RABV) and other lyssaviruses. In this study, we established novel serological neutralizing tests (NT) based on vesicular stomatitis virus pseudotypes possessing all 18 known lyssavirus glycoproteins. Applying this system to comparative NT against rabbit sera immunized with current RABV vaccines, we showed that the current RABV vaccines fail to elicit sufficient neutralizing antibodies against lyssaviruses other than to those in phylogroup I. Furthermore, comparative NT against rabbit antisera for 18 lyssavirus glycoproteins showed glycoproteins of some lyssaviruses elicited neutralizing antibodies against a broad range of lyssaviruses. This novel testing system will be useful to comprehensively detect antibodies against lyssaviruses and evaluate their cross-reactivities for developing a future broad-protective vaccine.

28 February 2022 in Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Verified
Journal Article
Closed access
YKYoshihiro Kaku
Yoshihiro Kaku
AOAkiko Okutani
Akiko Okutani
ANAkira Noguchi
Akira Noguchi
SISatoshi Inoue
Satoshi Inoue
KMKen Maeda
Ken Maeda
SMShigeru Morikawa
Shigeru Morikawa
Rabies is a highly neurotropic disease caused by rabies lyssavirus (RABV). Human rabies vaccines exist for pre- and postexposure prophylaxis; however, after clinical symptoms appear, the disease has an ∼100% mortality rate with no effective treatments available. In our previous study, mouse neuroblastoma cells transfected with a plasmid coding one clone of a single-chain variable fragment (scFv), scFv-P19, against RABV phosphoprotein (RABV-P) derived from an scFv phage-display library, before infection, exhibited reduced viral propagation after infection with the RABV-fixed strain, CVS11. In this study, we conducted epitope mapping of scFv-P19 through indirect fluorescent assay and Western blotting analysis against full-length and N- or C-terminal truncated RABV-P. Our results suggest that scFv-P19 targets a portion containing amino acids 47–52 at the N-terminus, which partially overlaps with the N-terminal nuclear export sequences. This provides insights into the underlying mechanism associated with inhibition of RABV by scFv-P19, while allowing for the design of additional scFv-based therapeutic studies for RABV by integrating appropriate delivery and application systems. Furthermore, the results of this study suggest that scFv-P19 may serve as an effective tool for investigating nuclear trafficking of RABV-P to explore the roles of RABV-P isoforms in rabies pathogenesis.